The global effort to accelerate the availability of rotavirus vaccines in the developing world reaches a landmark with the first infants vaccinated against rotavirus in Nicaragua. Nicaragua’s President Enrique Bolaños hosts the launch of nationwide rotavirus immunisation at his home in Managua.
With a successful track record of introducing immunisation programmes, Bolivia was well-placed to take a lead in deploying the rotavirus vaccine.
With the support of GAVI and its partners, Honduras successfully introduced the Rotavirus vaccine.
Guyana becomes the fourth GAVI-eligible country to introduce a vaccine against rotavirus, the primary cause of diarrhoea which is the second biggest killer of under-fives in developing countries.
The first children in a GAVI-eligible country in Africa to be vaccinated against rotavirus was in Khartoum, Sudan. By 2015, GAVI plans to support the introduction of this life-saving vaccine in some 40 countries, most of them in Africa, which have extremely high rates of death from rotavirus infections.
On 26 April 2012, Ghana became the first African country to introduce pneumococcal and rotavirus vaccines at the same time, simultaneously tackling the leading causes of the world’s two biggest childhood killers – pneumonia and diarrhoea.
With the introduction of rotavirus vaccines in Rwanda, children will be protected against the leading cause of severe diarrhoea. At the date of introduction, rotavirus was responsible for the lives of nearly 3,500 Rwandan children every year, accounting for 8.8 % of all under five deaths.
Moldova introduced rotavirus vaccines in its routine immunisation in July 2012. The vaccination coverage is over 90%.
1 August - despite a severe humanitarian crisis, the government of Yemen, supported by GAVI and its partners introduces rotavirus vaccine into its national immunisation programme. One million children born each year will be targeted.
In October 2012, Malawi became the 10th GAVI-eligible country to introduce rotavirus vaccines in its national immunization program. Rotavirus takes the lives of more than 2,500 Malawian children under five each year— accounting for 4.5 percent of all under-five deaths in Malawi. Studies in Malawi show that rotavirus vaccines are safe and effective against severe rotavirus disease and are a cost-effective intervention.
Accelerating access to rotavirus vaccines will not only save the lives of Armenian children but also lessen the tremendous economic and health burden of rotavirus disease, thereby contributing to poverty reduction and a growing economy.
In the margins of GAVI’s 2012 Partners Forum in Tanzania, the country successfully introduced simultaneously rotavirus and pneumococcal vaccines to protect its children.